Brazil's ANVISA grants Stratum Nutrition, Ayalla novel food approval for NEM brand eggshell membrane

Stratum Nutrition and Ayalla announced ANVISA, the National Health Surveillance Agency of the Brazilian Ministry of Health, granted “safety and efficacy as a bioactive substance” pre-market approval of NEM brand eggshell membrane.

Stratum Nutrition and Ayalla announced ANVISA, the National Health Surveillance Agency of the Brazilian Ministry of Health, granted “safety and efficacy as a bioactive substance” pre-market approval of NEM brand eggshell membrane. 

“NEM is an innovative science-based ingredient approved for the first time by ANVISA in Brazil,” said Sandra de Anselmo, president of Ayalla, in a press release. “We are very proud and excited to introduce such a robust ingredient to the Brazilian market and we are sure it will be a best-selling product in Brazil. We thank our partner, Stratum for the endless support they have given us through the approval process, and we hope to live up to their expectations just the same.”

Kevin J. Ruff, PhD, MBA, senior director of scientific and regulatory affairs for Stratum Nutrition, added: “Brazil marks the third rigorous regulatory agency review of NEM’s safety and efficacy data, following Canadian and Australian approvals in recent years. We are extremely gratified to receive approval from ANVISA, as this again validates the substantial scientific portfolio that supports NEM and its health claims. Brazil is a major market for joint health ingredients, and we believe that an innovative, scientifically backed ingredient like NEM will quickly establish itself as a category leader.”